Aliya Arynova

Head of RA/PV/QA/MA, Asia cluster

Professional Overview

Aliya Arynova is a seasoned pharmaceutical executive with extensive expertise in regulatory affairs, pharmacovigilance, quality assurance, and medical affairs. As the Head of RA/PV/QA/MA for the Asia cluster at Acino, she is responsible for overseeing the strategic alignment and operational excellence of these critical functions across the region.

Experience Summary

Current Role

In her current role at Acino, Aliya is instrumental in driving regulatory compliance, product safety, quality control, and medical support for the company's pharmaceutical portfolio in Asia. She leads a team of subject matter experts to ensure timely market authorizations, robust pharmacovigilance systems, and the maintenance of the highest quality standards. Under her leadership, the Asia cluster has achieved a remarkable track record of on-time product launches, enhanced pharmacovigilance monitoring, and seamless regulatory approvals.

Career Progression

Prior to joining Acino, Aliya held progressive leadership positions in the pharmaceutical industry, including stints as a Medical Manager at AstraZeneca and a Medical Director at Roche. Throughout her career, she has demonstrated a strong aptitude for navigating complex regulatory landscapes, driving cross-functional collaboration, and delivering impactful medical and safety initiatives. Her proven track record of driving operational excellence and fostering innovation has earned her a reputation as a respected industry leader.

Academic Background

Aliya holds a Master's degree in Pharmaceutical Sciences from the Kazakh National Medical University, where she graduated with distinction. Her academic achievements and ongoing professional development have equipped her with a deep understanding of the pharmaceutical industry's evolving regulatory and quality requirements.

Areas of Expertise

• Regulatory affairs and market access

• Pharmacovigilance and drug safety

• Quality assurance and compliance

• Medical affairs and medical information

• Strategic planning and operational management

• Cross-functional team leadership and collaboration

Professional Impact

Under Aliya's leadership, the Asia cluster of Acino has achieved significant milestones, including the successful launch of several new products, the implementation of robust pharmacovigilance systems, and the maintenance of impeccable quality standards. Her contributions have been instrumental in strengthening the company's market presence and positioning Acino as a trusted partner in the region.

Conclusion

Aliya Arynova's extensive experience and proven track record in the pharmaceutical industry make her a valuable asset to Acino. As the Head of RA/PV/QA/MA for the Asia cluster, she continues to drive operational excellence, foster innovation, and ensure the company's adherence to the highest regulatory and quality standards, positioning Acino for sustained growth and success in the region.